Skip to content

Depression: all studies

Page 816 of 1,034: studies 8,151 to 8,160 of 10,336, newest first. Back to the depression overview

Research

MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study

Scientific Reports November 24, 2020 Julane Andries, Lisa Jerome, Evan Sola et al. 170 citations

Abstract The success of modern medicine creates a growing population of those suffering from life-threatening illnesses (LTI) who often experience anxiety, depression, and existential distress. We present a novel approach; investigating MDMA-assisted psychotherapy for the treatment of anxiety in people with an LTI. Participants with anxiety from an LTI were randomized in a double-blind study to...

Impact of a University-Wide Interdisciplinary Mind-Body Skills Program on Student Mental and Emotional Well-Being.

Global Advances in Health and Medicine November 23, 2020 Brenna K Novak, Anna Gebhardt, Harini Pallerla et al.

Background: Positive effects of mind-body skills programs on participant well-being have been reported in health professions students. The success seen with medical students at this university led to great interest in expanding the mind-body skills program so students in other disciplines could benefit from the program. Objective: The purpose of this study was to assess the effects of a 9-week...

Can Meditation Control the Suicidal Thought? - A Spiritual Insight

Nepal Journal of Multidisciplinary Research November 23, 2020 Tej Bahadur Karki, Kalpana Khadka

Suicide is a social phenomenon and is mainly caused by mental disorder which may be attributed to by genetic, neurotic, and environmental constructs. A total of 5,124 people had committed suicide in the fiscal year 2016/17.The number rose to 5,317 in 2017/18 and to 5,785 in 2018/19. Various social and biological factors have significant roles to create the suicidal thought in depressed people....

Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy.

Psychopharmacology November 21, 2020 Allison A. Feduccia, Lisa Jerome, Michael C Mithoefer et al. 39 citations Retracted

Abstract Rationale MDMA-assisted psychotherapy is under investigation as a novel treatment for posttraumatic stress disorder (PTSD). The primary mechanism of action of MDMA involves the same reuptake transporters targeted by antidepressant medications commonly prescribed for PTSD. Objectives Data were pooled from four phase 2 trials of MDMA-assisted psychotherapy. To explore the effect of...

Meditation for Increased Mindfulness and Memory: An Analysis on the Impact of Meditation on Mindfulness and Working Memory Capacity in High School Students

Journal of Student Research November 20, 2020 Rebeccah Fleischmann, Michael I Posner

70% of high school students see anxiety and depression as a “major problem” among their peers (Pew Research Center). Meditation decreases anxiety and stress according to Harvard researchers. Stress and memory are very much connected as a recent study concluded that non-stressed people remember more items on average than stressed people. Although several studies have been done on the impacts of...

A review of common psychedelic drugs

Southern African Journal of Anaesthesia and Analgesia November 19, 2020 S Mayet 3 citations

Psychedelic substances have traditionally been used in medicine and religious rituals. Their use dates back thousands of years with fossil evidence as old as 10 000 years. Throughout the 1950s and 1960s psychedelics were used in clinical studies. These drugs then saw widespread use in hippie culture and were viewed as a drug of abuse with no medicinal value. Currently, psychedelics are being...

DOI: 10.36303/sajaa.2020.26.6.s3.2554 (opens in new tab) Addiction Drugs of abuse Value mathematics Psychotherapist

Discontinuing antidepressant medication after mindfulness-based cognitive therapy: a mixed-methods study exploring predictors and outcomes of different discontinuation trajectories, and its facilitators and barriers

BMJ Open November 12, 2020 Marloes J. Huijbers, Carolien Wentink, Anne E. M. Speckens et al.

Objectives This study aimed to explore predictors and outcomes associated with different trajectories of discontinuing antidepressant medication (ADM), in recurrently depressed individuals after participation in mindfulness-based cognitive therapy (MBCT). Facilitators and barriers of discontinuation were explored qualitatively.Design Mixed-methods study combining quantitative and qualitative...

Kétamine, psilocybine, et antidépresseurs d'action rapide : de nouvelles promesses pour la psychiatrie?

L'Encephale November 12, 2020 Hugo Bottemanne, Anne Claret, Philippe Fossati 10 citations

The hypothesis of monoaminergic deficiency has long dominated the conceptual framework for the development of new antidepressant strategies, but the limits of conventional antidepressant treatments targeting monoaminergic signaling have motivated the search for new antidepressant pathways. The success of ketamine in the management of depressive disorders has provoked a renewed interest in...

The feasibility of mindfulness-based cognitive therapy for people with bipolar disorder: a qualitative study.

International Journal of Bipolar Disorders November 11, 2020 Imke Hanssen, Nicole Van der Horst, Marieke Boele et al.

Mindfulness- Based Cognitive Therapy (MBCT) could be a promising psychosocial intervention for people with bipolar disorder (BD). However, little is known about the feasibility of MBCT for people with BD. In this study we explore the facilitators and barriers people with BD experience of an adapted MBCT program. This qualitative study is part of a large, multicenter randomized controlled trial...